Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group

Dig Liver Dis. 2020 Oct 22;S1590-8658(20)30976-2. doi: 10.1016/j.dld.2020.10.024.Online ahead of print.

Serena Arrigo 1, Patrizia Alvisi 2, Claudia Banzato 3, Matteo Bramuzzo 4, Fortunata Civitelli 5, Antonio Corsello 6, Giulia D'Arcangelo 7, Anna Di Lillo 8, Valeria Dipasquale 9, Enrico Felici 10, Maurizio Fuoti 11, Simona Gatti 12, Zeno Giusti 13, Daniela Knafelz 14, Paolo Lionetti 15, Federica Mario 16, Antonio Marseglia 17, Stefano Martelossi 16, Chiara Moretti 18, Lorenzo Norsa 19, Federica Nuti 20, Roberto Panceri 21, Stefania Rampado 16, Sara Renzo 15, Claudio Romano 9, Erminia Romeo 22, Caterina Strisciuglio 23, Massimo Martinelli 24


Author information

  • 1Pediatric Gastroenterology and Endoscopy Unit, Institute 'Giannina Gaslini', Genoa, Italy.
  • 2Pediatric Gastroenterology Unit, Maggiore Hospital, Bologna, Italy.
  • 3Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Division, University of Verona, Verona, Italy.
  • 4Institute for Maternal and Child Health, IRCCS Burlo Garofalo, Trieste, Italy.
  • 5Department of Gender diseases, Child and Adolescent health, Pediatric unit, Sant'Eugenio Hospital, Rome, Italy.
  • 6Fondazione Policlinico Universitario A. Gemelli IRCCS, OU Internal Medicine and Gastroenterology, Rome, Italy.
  • 7Women's and Children's Health Department, Pediatric Gastroenterology and Hepatology Unit, Sapienza University of Rome, Rome, Italy.
  • 8Pediatric and Neonatology Unit, Sapienza University of Rome, Santa Maria Goretti Hospital, Latina, Italy.
  • 9Paediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Italy.
  • 10Pediatric and Pediatric Emergency Unit, "Umberto Bosio" Center for Digestive Diseases, The Children Hospital, AO SS Antonio e Biagio e C. Arrigo, Alessandria, Italy.
  • 11Pediatric Gastroenterology and GI Endoscopy, University Department of Pediatrics, Children's Hospital, Spedali Civili, Brescia, Italy.
  • 12Department of Pediatrics, Università Politecnica delle Marche, Ancona, Italy.
  • 13Department of Translational Medical Science, Section of Pediatrics, University of Naples "Federico II", , Via S. Pansini, 5, 80131 Naples, Italy.
  • 14Hepatology and Gastroenterology Unit, Bambino Gesù Hospital, Rome, Italy.
  • 15University of Florence-Meyer Hospital, Florence, Italy.
  • 16Pediatric Unit, Ca' Foncello's Hospital, Treviso, Italy.
  • 17Fondazione IRCCS Casa Sollievo della Sofferenza, Division of Pediatrics, San Giovanni Rotondo, Italy.
  • 18Paediatrics Division, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • 19Paediatric Hepatology Gastroenterology and Transplantation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • 20Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Pediatric Intermediate Care Unit, Milan, Italy.
  • 21Department of Pediatrics, University of Milano-Bicocca, Foundation MBBM/San Gerardo Hospital, Monza, Italy.
  • 22Digestive Surgery and Endoscopy Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • 23Department of Woman, Child and General and Specialistic Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • 24Department of Translational Medical Science, Section of Pediatrics, University of Naples "Federico II", , Via S. Pansini, 5, 80131 Naples, Italy. Electronic address: massimo.martinelli@unina.it.


Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2, spreading in Italy during the first months of 2020, abruptly changed the way of practicing medicine in this country. As a consequence of the lockdown, the diagnostic and therapeutic management of paediatric chronic conditions, such as inflammatory bowel disease (IBD) has been affected. During the peak of COVID-19 pandemic, elective visits, endoscopies and infusions have been postponed, with potential clinical and psychological impact on disease course and a high likelihood of increasing waiting lists. While slowly moving back towards normality, clinicians need to recognize the best ways to care for patients with IBD, carefully avoiding risk factors for new potential epidemic outbreaks. In this uncertain scenario until the development and spread of COVID-19 vaccine, it is necessary to continue to operate with caution. Hereby we provide useful indications for a safer and gradual restarting of routine clinical activities after COVID-19 peak in Italy.

© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.